On this page
Yartemlea
narsoplimab-wuug
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Yartemlea
Proper name
narsoplimab-wuug
Licence type
351(a)
BLA number
761152
Applicant
Omeros Corporation
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 370MG/2ML | Injection | Intravenous | Single-Dose Vial | Rx | December 23, 2025 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |